Pulmonary Neoplasm
16
5
6
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
6.3%
1 terminated out of 16 trials
80.0%
-6.5% vs benchmark
6%
1 trials in Phase 3/4
0%
0 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (16)
Effect of High-Flow Nasal Cannula Oxygen Therapy on Hypoxemia in Pediatric Sedated Bronchoscopy
Enhanced COPD Management in Suspected Lung Cancer Patients
Erector Spinae Block for Thoracic Surgery
Precision Lung Cancer Survivorship Care Intervention
Impact of Different Lung Isolation Devices on Pharyngolaryngeal Injuries After Pulmonary Resection
The Natural History and Biological Study of Pulmonary Recurrent Respiratory Papillomatosis (pRRP)
Rarecells Molecular Biomarkers for Early Detection of Lung Cancer
Safety and Feasibility of Surgery After Conversion Therapy for Locally Advanced and Advanced NSCLC
Robot-assisted vs VATS Lobectomy for NSCLC
FGFR Inhibitor in FGFR Dysregulated Cancer
Effect of Muscle and Skin Fixation of Thoracic Drainage Tube on Postoperative Pain
Effect of Pulmonary Rehabilitation on Perioperative Outcomes in Smoker Patients With Lung Cancer
ENB Vs. Conventional Bronchoscopy With Fluoroscopy for Safe and Effective Biopsy of Pulmonary Lesions
Modified Versus Traditional Thoracic Drainage After Thoracoscopic Surgery
Could the Stroke Volume Variation Predict a Fluid Responsiveness in Thoracotomy?
Trial of Pre-operative Chemoradiotherapy Followed by Surgical Resection in Pancoast Tumors (JCOG 9806)